On June 17, 2025, Biomea Fusion, Inc. announced positive preclinical findings for its weight loss candidate BMF-650, showing a 12% and 15% average weight reduction in obese monkeys over 28 days with daily doses of 10 mg/kg and 30 mg/kg, respectively.